Mélanie White‐Koning

3.5k total citations · 1 hit paper
44 papers, 2.6k citations indexed

About

Mélanie White‐Koning is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Psychology and Oncology. According to data from OpenAlex, Mélanie White‐Koning has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 10 papers in Clinical Psychology and 9 papers in Oncology. Recurrent topics in Mélanie White‐Koning's work include Infant Development and Preterm Care (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Cerebral Palsy and Movement Disorders (8 papers). Mélanie White‐Koning is often cited by papers focused on Infant Development and Preterm Care (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Cerebral Palsy and Movement Disorders (8 papers). Mélanie White‐Koning collaborates with scholars based in France, United Kingdom and Denmark. Mélanie White‐Koning's co-authors include Jennifer J. Kurinczuk, Nadia Badawi, Catherine Arnaud, Allan Colver, Étienne Chatelut, Eva Beckung, Jérôme Fauconnier, Ute Thyen, Kathryn Parkinson and Susan Ishøy Michelsen and has published in prestigious journals such as PEDIATRICS, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Mélanie White‐Koning

42 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy

2010 950 citations Mélanie White‐Koning et al. profile →

Peers

Countries citing papers authored by Mélanie White‐Koning

Since Specialization

Citations

This map shows the geographic impact of Mélanie White‐Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie White‐Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie White‐Koning more than expected).

Fields of papers citing papers by Mélanie White‐Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie White‐Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie White‐Koning. The network helps show where Mélanie White‐Koning may publish in the future.

Co-authorship network of co-authors of Mélanie White‐Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie White‐Koning. A scholar is included among the top collaborators of Mélanie White‐Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie White‐Koning. Mélanie White‐Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium 2025 ·Therapies ·Jean‐Baptiste Woillard, Sébastien Benzekry, Julie Josse, Mélanie White‐Koning, Étienne Chatelut, Emmanuelle Comets, F. Lemaı̂tre, (unknown), Matthieu Grégoire, Françoise Stanke‐Labesque, Sarah Zohar, Moreno Ursino, Christophe Battail	0
2	Morphometric analysis of neoplastic cell clusters in high-grade serous ovarian cancer ascites identifies a promising prognostic factor: a retrospective study 2025 ·Journal of Ovarian Research ·Benoît Thibault, Romina D’Angelo, (unknown), Mélanie White‐Koning, Guillaume Bataillon, Julie Guillermet‐Guibert, Céline Basset	1
3	Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study 2024 ·Clinical Pharmacokinetics ·Mélanie White‐Koning, Daniel F. B. Wright, Dyfrig Hughes, (unknown), (unknown), Parisa Aslani, Richard O. Day, Sophie L. Stocker	1
4	Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model 2022 ·Frontiers in Medicine ·(unknown), (unknown), Carine Pestourie, Manuel Bardiès, (unknown), Pierre Payoux, Étienne Chatelut, Mélanie White‐Koning, Anne‐Sophie Salabert	4
5	Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr 2021 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Florent Puisset, Fabienne Thomas, Étienne Chatelut, Mélanie White‐Koning	24
6	Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data 2021 ·Pharmaceuticals ·(unknown), (unknown), Fabienne Thomas, Mélanie White‐Koning, Ben Allal, Caroline Protin, Loïc Ysebaert, Étienne Chatelut, Florent Puisset	4
7	Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance 2020 ·Cancer Chemotherapy and Pharmacology ·Mélanie White‐Koning, (unknown), (unknown), Laurence Gladieff, Christine Chevreau, Étienne Chatelut, Florent Puisset	13
8	Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies 2020 ·Clinical Pharmacokinetics ·(unknown), Loïc Ysebaert, Fabien Despas, Sandra De Barros, Loı̈c Dupré, Anne Quillet‐Mary, Caroline Protin, Fabienne Thomas, Lucie Obéric, Ben Allal, Étienne Chatelut, Mélanie White‐Koning	15
9	Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients 2019 ·Clinical Therapeutics ·Marie Allard, Alicja Puszkiel, Filomena Conti, L Chevillard, Nassim Kamar, Gaëlle Noé, Mélanie White‐Koning, Audrey Thomas‐Schoemann, Tabassome Simon, Michel Vidal, Yvon Calmus, Benoı̂t Blanchet	6
10	Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence 2018 ·European Journal of Cancer ·Mélanie White‐Koning, Caroline Osborne, Angélo Paci, Alan V. Boddy, Étienne Chatelut, Gareth J. Veal	7
11	Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients 2016 ·Pharmacological Research ·Alicja Puszkiel, Mélanie White‐Koning, N. Dupin, N. Kramkimel, Audrey Thomas‐Schoemann, Gaëlle Noé, Nicolas Chapuis, Michel Vidal, François Goldwasser, Étienne Chatelut, Benoı̂t Blanchet	5
12	Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin 2016 ·Pharmacological Research ·Chloé Sauzay, Mélanie White‐Koning, Isabelle Hennebelle, (unknown), Caroline Delmas, (unknown), Étienne Chatelut, Fabienne Thomas	29
13	Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown), Mélanie White‐Koning, (unknown), Isabelle Lochon, (unknown), Laurence Gladieff, Étienne Chatelut, Gwénaël Ferron	30
14	Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents 2012 ·British Journal of Cancer ·Étienne Chatelut, Mélanie White‐Koning, Ron H.J. Mathijssen, Florent Puisset, Sharyn D. Baker, Alex Sparreboom	68
15	Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma 2009 ·European Journal of Cancer ·Fabienne Thomas, Philippe Rochaix, Mélanie White‐Koning, Isabelle Hennebelle, Jérôme Sarini, A. Benlyazid, (unknown), Jean‐Louis Lefebvre, Étienne Chatelut, Jean Pierre Delord	68
16	Psychological problems in children with hemiplegia: a European multicentre survey 2009 ·Archives of Disease in Childhood ·Jacqueline Parkes, Mélanie White‐Koning, Norman B. McCullough, (unknown)	25
17	Psychological problems in children with cerebral palsy: a cross‐sectional European study 2008 ·Journal of Child Psychology and Psychiatry ·Jackie Parkes, Mélanie White‐Koning, Heather O Dickinson, Ute Thyen, Catherine Arnaud, Eva Beckung, Jérôme Fauconnier, Marco Marcelli, Vicki McManus, Susan Ishøy Michelsen, Kathryn Parkinson, Allan Colver	164
18	Health status of children with cerebral palsy living in Europe: a multi‐centre study 2008 ·Child Care Health and Development ·Eva Beckung, Mélanie White‐Koning, Marco Marcelli, Vicki McManus, Susan Ishøy Michelsen, J. Parkes, Kathryn Parkinson, Ute Thyen, Catherine Arnaud, Jérôme Fauconnier, Allan Colver	44
19	Subjective quality of life in children with intellectual impairment – how can it be assessed? 2005 ·Developmental Medicine & Child Neurology ·Mélanie White‐Koning, Catherine Arnaud, (unknown), (unknown), Allan Colver, H. Grandjean	70
20	Incidence of childhood leukaemia in the vicinity of nuclear sites in France, 1990–1998 2004 ·British Journal of Cancer ·Mélanie White‐Koning, Denis Hémon, Dominique Laurier, M. Tirmarche, Éric Jougla, A Goubin, Jacqueline Clavel	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact